Global Health Ltd - 543654 - Approved The Unaudited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2023
Financial Results for quarter and nine months ended Dec 31, 2023.08-02-2024
08-02-2024
Global Health Ltd - 543654 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Dear Sir(s), We would like to inform you that the Board of Directors of Global Health Limited ('GHL/Company') at its meeting held today i.e. Thursday, February 8, 2024, inter-alia, approved the Unaudited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2023 ('Results'), Attached herewith.08-02-2024
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an Earnings Conference Call is scheduled on Friday, February 9, 2024 at 2:00 P.M. (IST) to be hosted by Motilal Oswal, for the third quarter and nine months ended December 31, 2023 results of the Company. Kindly take the above on record.02-02-2024
Global Health Ltd - 543654 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Both Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended December 31, 2023.
Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve the Unaudited Financial Results (both standalone and consolidated) of the Company for the third quarter and nine months ended December 31, 2023.30-01-2024
Bill Gates Says Global Health Spending Key To Halting Climate Change
Bill Gates believes a key way to combat climate change is improving access to health care in developing countries, an area the billionaire philanthropist worries that governments are neglecting.16-01-2024
Global Health Ltd - 543654 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI DP, Regulations, 2018 for the Quarter Ended December 31, 2023.10-01-2024
Global Health (Medanta) share scales 52 highs, more than doubles in 1 year. Should you Buy, Sell or Hold the stock?
Stock market today: Global Health (Medanta) stock that has more than doubled in last one year, scaled 52 week highs on Friday. Analysts expect more gains led by scale-up in new and existing hospitals, ongoing expansions and a better operating leverage.07-01-2024
Global Health (Medanta) share scales 52 highs, more than doubles in 1 year. Should you Buy, Sell or Hold the stock?
Stock market today: Global Health (Medanta) stock that has more than doubled in last one year, scaled 52 week highs on Friday. Analysts expect more gains led by scale-up in new and existing hospitals, ongoing expansions and a better operating leverage.05-01-2024
Global Health Ltd - 543654 - Closure of Trading Window
This is to inform that as per SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing, buying or selling in the Shares of the Company shall remain closed from January 1, 2024 and shall open after 48 hours from declaration of unaudited financial results for Q3 ending December 31, 2023.29-12-2023
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that representatives of the Investor/Analyst are scheduled to meet the Company's Management representatives , as per schedule attached.19-12-2023